Testing for the antibodies, which create a built-in immunity, could help clear hospital staff, emergency responders and others to get back to work, indicating those who have had prior exposure and subsequent immunity to the disease, said Dr.
Once the tests are finalized, Beckman Coulter said it intends to follow the FDA’s process established March 16 in response to the public health emergency.
“This type of understanding could help determine … those who would require a vaccine once available or when an infected individual could safely return to work.” (trade name Beckman Coulter Diagnostics) is in the Surgical and Medical Instruments business. “Antibody assays play a critical role in understanding the measure of immunity an individual has developed against SARS-CoV-2,” said Kathleen Orland with Beckman Coulter’s chemistry and immunoassay business. WASP, WASPLab, C-Tracer, MALDI-Trace, SYNAPSE ProMINI, FLOQSwabs, ESwabandUTMareregistered trademarks or trademarks of Copan ItaliaSpA.Beckman Coulter in Brea developing coronavirus antibodies test – Orange County Register Close Menuīrea-based Beckman Coulter said Tuesday, March 31 it is developing tests, or assays, to identify antibodies created in people recovering from a novel coronavirus infection. For more information, visit Beckman Coulter, the stylized logo and Micro Scan are trademarks of Beckman Coulter, Inc. COPAN’s collaborative approach to pre-analytics has laboratory automation solutions, WASP and WASPLab. Its current headquarters are in Brea, California. With a reputation for innovation, COPAN is the leading manufacturer of collection and transport systems in the world. The company eventually grew to employ over 12,000 people, with 5.8 billion in annual sales by 2017. For more information, visit About COPAN Group Beckman Coulter is dedicated to advancing healthcare for every person and moving science, innovation and the lab forward. For 80 years, Beckman Coulter has been a global leader devoted to providing solutions to laboratories of all sizes, offering a broad portfolio of chemistry, immunoassay, hematology, urinalysis, microbiology, automation and information systems. Beckman Coulter’s instruments, systems and tests help streamline processes to enhance efficiency, reduce costs and speed the delivery of results. In addition to WASPLab, the amendment allows Beckman Coulter to distribute COPAN’s C- Tracer, SYNAPSEPro MINI and MALDI-Trace products.īeckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. added, “ COPAN has always been committed to provide open platform solutions to our customers and this partnership is further evidence and reinforcement of our ability to integrate and interface with important platforms in microbiology.” Stefania Triva, COPAN Group’s CEO said, “ Thisisanewstepinthecollaborationbetweenthe two companies and we look forward to continue working together to expand our reach.” Norman Sharples, Executive VP and Co-Founder of COPAN Diagnostics, Inc. “ COPAN’sproductscomplementournewlyacquiredMicroScan brand of microbiology solutions and offer hospitals and private laboratories a complete solution which streamlines workflow-demonstrating Beckman Coulter’s commitment to growth and is invested in this new area of our business.”
“ We’re very excited to expand our relationship with COPAN to offer clinical microbiology laboratories an extended portfolio of products to help provide physicians with the critical information they need regarding bacteria resistance,” said Arnd Kaldowski, president, Beckman Coulter Diagnostics. The amendment grants Beckman Coulter distribution rights in 21 global markets, including a number of territories in North America, Asia (including, among other territories, Japan and China), Europe, South America and many emerging markets. Beckman Coulter Diagnostics Medical Devices Brea, California 209,482 followers Helping to advance healthcare for every person by applying the power of science and technology.
#BECKMAN COULTER BREA FULL#
Additional products include COPAN’s WASPLab automated, front-end robotic specimen processing, full lab automation and digital microbiology system. Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and COPAN, a company committed to innovation in the field of pre-analytics, today announced that Beckman Coulter Diagnostics and COPAN Group have entered into an amendment to their distribution agreement that expands their relationship into new products and geographic territories.